Matches in Wikidata for { <http://www.wikidata.org/entity/Q65368753> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q65368753 description "clinical trial" @default.
- Q65368753 description "ensayu clínicu" @default.
- Q65368753 description "klinisch onderzoek" @default.
- Q65368753 description "клінічне випробування" @default.
- Q65368753 name "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 name "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 type Item @default.
- Q65368753 label "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 label "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 prefLabel "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 prefLabel "Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 P1050 Q65368753-2786F262-4FC7-4046-BED0-031BF6340CA4 @default.
- Q65368753 P1132 Q65368753-76D22A1E-A9A3-4BCB-9EAA-E09D8C979EB9 @default.
- Q65368753 P1476 Q65368753-E4049812-3D5F-410C-B328-E1BE00BC42E3 @default.
- Q65368753 P17 Q65368753-4ECDE725-8DC1-4395-89F7-3110896C560C @default.
- Q65368753 P17 Q65368753-6CA0D8F4-D2F3-43EB-986F-2277D98F0BC4 @default.
- Q65368753 P2899 Q65368753-6AB339C9-EFE1-400E-AB3E-B10733CE594E @default.
- Q65368753 P3098 Q65368753-0B516F73-B1E5-4128-A8A7-A78946D3E6D7 @default.
- Q65368753 P31 Q65368753-624C25CB-E647-4C91-A46C-147DACF63CA6 @default.
- Q65368753 P580 Q65368753-18995EE8-0D3A-4C0C-A0CC-7348B954CB6A @default.
- Q65368753 P582 Q65368753-8F188F5C-E7D4-4065-A433-E7F6781DD4EA @default.
- Q65368753 P6099 Q65368753-22E86EC9-F98E-4134-B44C-6ADE4B5A4A2C @default.
- Q65368753 P6153 Q65368753-328994EA-E3CF-4B91-BDFE-4C7F619FA997 @default.
- Q65368753 P6153 Q65368753-4FD459BC-DC93-4CB1-9490-C1F99AAF5FF5 @default.
- Q65368753 P6153 Q65368753-619F5262-7F74-4ABB-AFA3-F531D00EAA9E @default.
- Q65368753 P6153 Q65368753-65AF0361-18A1-4E52-A0B1-C1956A8DC397 @default.
- Q65368753 P6153 Q65368753-67EBB48F-6D75-49BB-B37A-D2A960433213 @default.
- Q65368753 P6153 Q65368753-97AE51C4-8E73-47DF-957C-C70CAA9D4DFB @default.
- Q65368753 P6153 Q65368753-A2308B0D-0BBD-4783-92A4-6FD43B5EFE01 @default.
- Q65368753 P6153 Q65368753-C96C60CC-4CAD-4F6D-A08A-85628BD482B6 @default.
- Q65368753 P6153 Q65368753-DD8140EE-851D-4C35-B241-9189EBEA03D7 @default.
- Q65368753 P6153 Q65368753-FEB89D11-E4DB-4E48-A08D-E0B4CB190AAC @default.
- Q65368753 P8363 Q65368753-8971F3B1-CA94-442F-B1D3-D78B7D6E30F0 @default.
- Q65368753 P1050 Q208414 @default.
- Q65368753 P1132 "+326" @default.
- Q65368753 P1476 "A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies" @default.
- Q65368753 P17 Q16 @default.
- Q65368753 P17 Q30 @default.
- Q65368753 P2899 "+18" @default.
- Q65368753 P3098 "NCT01799889" @default.
- Q65368753 P31 Q30612 @default.
- Q65368753 P580 "2013-03-14T00:00:00Z" @default.
- Q65368753 P582 "2017-09-14T00:00:00Z" @default.
- Q65368753 P6099 Q42824440 @default.
- Q65368753 P6153 Q131252 @default.
- Q65368753 P6153 Q1472663 @default.
- Q65368753 P6153 Q219563 @default.
- Q65368753 P6153 Q230492 @default.
- Q65368753 P6153 Q30269842 @default.
- Q65368753 P6153 Q309331 @default.
- Q65368753 P6153 Q4117596 @default.
- Q65368753 P6153 Q46992910 @default.
- Q65368753 P6153 Q5123723 @default.
- Q65368753 P6153 Q7851547 @default.
- Q65368753 P8363 Q78089383 @default.